Catastrophic Candida prosthetic valve endocarditis and COVID-19 comorbidity: A rare case

Area of Science:

• Infectious Diseases
• Cardiology
• Critical Care Medicine

Background:

• Distinguishing Coronavirus disease 2019 (COVID-19) from Candida prosthetic valve endocarditis is challenging due to overlapping clinical presentations.
• Patients with prosthetic cardiac valves are at increased risk for severe outcomes when co-infected with COVID-19 and fungal pathogens.

Purpose of the Study:

• To report a case of Candida tropicalis prosthetic valve endocarditis in a patient with COVID-19.
• To emphasize the critical need for prompt diagnosis and antifungal intervention in such complex cases.

Main Methods:

• A 66-year-old male with a history of valve replacement presented with symptoms suggestive of both COVID-19 and endocarditis.
• Diagnostic tools included transesophageal echocardiography, chest CT scan, RT-PCR for COVID-19, and blood cultures.
• The patient received antifungal therapy but unfortunately succumbed to septic shock.

Main Results:

• The patient presented with fever, respiratory distress, neurological symptoms, and hypoxia.
• Echocardiography revealed large vegetations on the mechanical mitral valve.
• Blood cultures identified Candida tropicalis, and COVID-19 was confirmed via RT-PCR.

Conclusions:

• This case underscores the critical importance of early diagnosis and prompt antifungal treatment in COVID-19 patients with prosthetic cardiac valves.
• Failure to rapidly initiate antifungal therapy can lead to unfavorable outcomes, including mortality.
• Integrated management strategies are essential for co-infected patients to mitigate risks.